Navigation Links
Access Hybritech PSA Test

ProductsAccess Hybritech PSA Test
Company Beckman Coulter, Inc.
Item Access Hybritech PSA Test
Features 
  • Original Hybritech PSA monoclonal antibody pair now on Access!
  • Equimolar PSA measurement
  • Time to first result: 20 minutes
  • Curve stability: 28 days
  • Analytical sensitivity: <0.008 ng/mL
  • Measurement range: to 150 ng/mL
  • Precision: < 5% CV across assay range
Description A blood test, called the Prostate Specific Antigen (total PSA) test, has been used to help doctors decide how to manage patients with prostate cancer. Of the different PSA blood tests available, the Hybritech PSA test, was the first approved for the detection of prostate cancer when used in combination with digital rectal examination (DRE) in men aged 50 years or older.

Depending on the results of your DRE and total PSA test, your physician may decide to order an additional blood test, called free PSA. This test is used to help the physician interpret the results when the total PSA test, combined with a non-suspicious DRE, are ambiguous.

Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com

Related medicine products :

1. Access Immunoassay System
2. Access 2 Immunoassay System
3. Access Dilation Port
4. PINNACLE Introducer Sheath Designed for Vascular Access
5. FLEXOR CHECK-FLO Introducer Sets for Radial Artery Access with AQ Hydrophylic Coating
6. CHECK-FLO Performer Introducer Sets For Radial Artery Access
7. CHECK-FLO Performer Introducer Sets Micropuncture Access
8. XPOSE 3 Access Device
9. XTD Hemodialysis Access Graft Thrombectomy Catheter
10. BD Visitrec Vitrectomy Unit and Accessories
11. EBI Access Pelvic Fixator
Megakwik Malaria ( P.falciparum ) Card Test...
The KAT-Quick Malaria test was designed for the diagnosis of Malaria, in laboratories, the home and for medical kits when travelling into malaria regions....
OptiMAL is a malaria test, for diagnosis and therapy control of an infection by Plasmodium species (Malaria)....
... based system with up to 40 patients in ... for up to 20 patients. Dual PC central ... monitoring and workstation. Multi PC central station for ... and two monitoring stations. Immediate response time through ...
Medicine Products:
(Date:2/23/2017)... MELBOURNE, Australia (PRWEB) , ... February 23, 2017 , ... ... . With perseverance and disciplined exercise regime, the author was able to successfully recover. ... Vas-Don collates all relevant information for various sources on the principals of massage, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... in recent years. The technology is so cutting edge, in fact, the U.S. ... for stem cell procedures. However, successful patient outcomes in certain clinical stem cell ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... approach, leads to fewer trips the emergency room, fewer hospital admissions, and better ... Journal of Managed Care® (AJMC®) finds. The study can be found here ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World Horse Expo ... Tom Seay and his production crew. Tom Seay’s program “Best of America by ... Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, the ...
(Date:2/22/2017)... ... 22, 2017 , ... The Centers for Medicare & Medicaid ... in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in ... Act of 2015 (MACRA). , This technical assistance, authorized and funded under ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... York , February 23, 2017 ... Holter Monitor Market are GE Healthcare, Koninklijke Philips N.V., ... about 48% in the global market in 2015. Strong ... two key factors assessed to be aiding these players ... Research states that the players in the global market ...
(Date:2/23/2017)... Mass. , Feb. 23, 2017   ... partner to global in vitro diagnostics manufacturers and ... series titled "Catalyzing Implementation of NGS-Based Tests" to ... March 30, 2017 at 11am Eastern Standard Time ... is to highlight the need for improved performance ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology: